The difference of genetic background may lead to the differential expression of NFE2L3; meanwhile, the human liver cancer cell lines established in vitro will undergo a transformation, including gene loss, drift, etc. More importantly, tumor cells are polymorphic, and the differential expression of NFE2L3 is the cause of tumor heterogeneity. The gene discussed is NFE2L3; the disease is liver cancer.